How does Private Label pricing work?
There's an R&D development fee (covers formulation, sampling, stability testing) and a per-unit production cost. The development fee is a one-time investment. Per-unit costs decrease with volume. We quote both upfront before you commit — no hidden charges after the brief stage.
What's the minimum volume commitment?
Minimums vary by format and complexity. Capsules and powders have lower thresholds than gummies or functional drinks. We'll give you exact numbers during the specification stage — they're typically lower than what legacy contract manufacturers require.
Do you sign exclusivity?
Yes — for specific ingredient combinations within a defined category. We won't manufacture a directly competing formula for another client in the same market segment during your contract. The scope is documented in the agreement.
What happens if we want to take production elsewhere?
You own the formula. You can take it elsewhere at any time, subject to the notice period in your contract. We'll provide a technology transfer package — formula documentation, specifications, supplier contacts (where agreements allow) — to make the transition smooth.
Can you handle rare or novel ingredients?
In most cases, yes. Our sourcing network covers clinical-grade branded ingredients, specialty botanicals, and novel food ingredients approved under EU regulation. If an ingredient requires novel food authorization, we'll flag it early and advise on timeline and cost implications.
How does this differ from White Label with custom packaging?
White Label = our formula, your brand. Private Label = your formula, your brand. With White Label, you choose from the existing catalog and customize packaging. With Private Label, the formulation itself is custom — built to your specification, owned by you as IP.
Can we trial with one Private Label SKU before committing?
Absolutely. Most brands start with a single SKU to validate the process, the product, and the partnership. If it works, expanding to additional SKUs is faster because the framework — NDA, quality standards, communication cadence — is already in place.
If we develop a formula together and it doesn't launch, who owns the IP?
You do. Once the formula reaches a stable version and the development fee is paid, the IP is yours regardless of whether you proceed to production. The formula doesn't revert to us if you choose not to launch.